We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sloane Upchurch Convey’s office at (408) 847-1739 to ask if they take your plan before you enroll.
California Medical Board record
Licence C20318 · Cancelled
Licence status: Cancelled · since 1958 · University of Colorado School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$19,096
Medicare paid this office $19,096 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Short return visit (20+ min)
177
$9,431
$45
Mri scan of lower spinal canal without contrast
37
$2,680
$72
Mri scan of upper spinal canal without contrast
20
$1,567
$78
X-ray of lower and sacral spine, minimum of 4 views
35
$882
$25
X-ray of lower and sacral spine, 2-3 views
37
$807
$22
See all 8 services
Every Original Medicare service billed
Short return visit (20+ min)
177
$9,431
$45
Mri scan of lower spinal canal without contrast
37
$2,680
$72
Mri scan of upper spinal canal without contrast
20
$1,567
$78
X-ray of lower and sacral spine, minimum of 4 views
35
$882
$25
X-ray of lower and sacral spine, 2-3 views
37
$807
$22
3d radiographic procedure
56
$555
$10
X-ray of upper spine, 2-3 views
13
$312
$21
Short return visit
12
$283
$24
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 73 · Women 58% · Health risk score 0.98. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
The office billed $109,522, Medicare allowed $29,033 and paid $19,096; for 480 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
238
480
73
0.98
$109,522
$19,096
2023
666
1,557
73
0.96
$343,403
$72,880
2022
548
1,323
72
0.87
$294,460
$64,939
2021
382
910
72
0.86
$221,695
$48,766
2020
408
845
71
0.97
$204,923
$43,306
2019
505
1,208
71
0.94
$247,121
$61,964
2018
452
969
70
1.00
$200,442
$51,630
2017
169
428
70
1.18
$72,751
$25,151
2016
323
890
69
1.13
$167,729
$48,839
2015
186
482
69
1.08
$54,301
$21,894
2013
73
106
70
2.00
$12,073
$3,828
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
Original Medicare services billed in 2023
Short return visit (20+ min)
509
$40,186
$54
Mri scan of lower spinal canal without contrast
126
$11,679
$89
X-ray of lower and sacral spine, 2-3 views
135
$3,567
$24
Mri scan of upper spinal canal without contrast
36
$3,260
$86
X-ray of lower and sacral spine, minimum of 4 views
78
$2,390
$30
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
16
$2,019
$112
X-ray of upper spine, 2-3 views
62
$1,801
$22
3d radiographic procedure
161
$1,800
$10
New patient visit (30+ min)
23
$1,404
$61
Testing for presence of drug, by chemistry analyzers
16
$1,096
$61
Short return visit
26
$857
$32
X-ray of upper spine, 4-5 views
22
$596
$27
2022: 11 services
Original Medicare services billed in 2022
Short return visit (20+ min)
379
$26,773
$55
Mri scan of lower spinal canal without contrast
118
$16,386
$73
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
36
$4,514
$113
Mri scan of upper spinal canal without contrast
32
$3,957
$68
X-ray of lower and sacral spine, 2-3 views
102
$2,684
$25
Testing for presence of drug, by chemistry analyzers
36
$2,452
$61
3d radiographic procedure
148
$1,528
$10
X-ray of lower and sacral spine, minimum of 4 views
44
$1,398
$32
X-ray of upper spine, 2-3 views
43
$1,274
$24
Short return visit
23
$720
$30
X-ray of upper spine, 4-5 views
16
$506
$32
2021: 9 services
Original Medicare services billed in 2021
Mri scan of lower spinal canal without contrast
99
$14,677
$72
Short return visit (20+ min)
189
$12,109
$59
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
52
$7,324
$114
Testing for presence of drug, by chemistry analyzers
52
$3,915
$62
Mri scan of upper spinal canal without contrast
23
$3,183
$69
X-ray of lower and sacral spine, 2-3 views
79
$1,980
$24
3d radiographic procedure
122
$1,192
$9
X-ray of upper spine, 2-3 views
31
$906
$25
X-ray of lower and sacral spine, minimum of 4 views
19
$615
$32
2020: 10 services
Original Medicare services billed in 2020
Mri scan of lower spinal canal without contrast
91
$13,064
$78
Short return visit (20+ min)
189
$8,984
$43
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
60
$7,390
$114
Mri scan of upper spinal canal without contrast
21
$2,420
$67
X-ray of lower and sacral spine, 2-3 views
101
$2,400
$23
Testing for presence of drug, by chemistry analyzers
37
$2,325
$61
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
11
$1,688
$153
3d radiographic procedure
108
$1,064
$9
X-ray of upper spine, 2-3 views
34
$921
$24
Short return visit
15
$373
$25
2019: 11 services
Original Medicare services billed in 2019
Short return visit (20+ min)
367
$21,104
$44
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
107
$16,052
$111
Testing for presence of drug, by chemistry analyzers
103
$8,629
$63
Mri scan of lower spinal canal without contrast
50
$5,202
$102
X-ray of lower and sacral spine, 2-3 views
121
$3,256
$23
Mri scan of upper spinal canal without contrast
28
$2,746
$98
X-ray of upper spine, 2-3 views
37
$1,280
$23
X-ray of lower and sacral spine, minimum of 4 views
37
$1,223
$32
3d radiographic procedure
75
$758
$10
X-ray of upper spine, 4-5 views
20
$642
$32
Short return visit
16
$464
$29
2018: 8 services
Original Medicare services billed in 2018
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
119
$15,700
$112
Short return visit (20+ min)
329
$15,210
$41
Testing for presence of drug, by chemistry analyzers
109
$8,799
$70
Mri scan of lower spinal canal without contrast
33
$3,552
$108
X-ray of lower and sacral spine, 2-3 views
102
$2,327
$22
X-ray of upper spine, 2-3 views
37
$709
$19
3d radiographic procedure
52
$513
$10
X-ray of lower and sacral spine, minimum of 4 views
13
$368
$28
2017: 4 services
Original Medicare services billed in 2017
Short return visit (20+ min)
134
$8,450
$44
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
53
$8,093
$114
Testing for presence of drug, by chemistry analyzers
53
$5,725
$77
Injection, methylprednisolone acetate, 20 mg
14
$47
—None
2016: 7 services
Original Medicare services billed in 2016
Short return visit (20+ min)
224
$14,547
$43
Return visit (30+ min)
146
$11,768
$64
Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when
89
$9,552
$78
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
81
$8,617
$78
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
13
$1,808
$121
Injection of trigger points, 1-2 muscles
19
$634
$32
Injection, methylprednisolone acetate, 20 mg
23
$72
—None
2015: 7 services
Original Medicare services billed in 2015
Return visit (30+ min)
93
$7,092
$69
Short return visit (20+ min)
111
$6,020
$46
Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
29
$3,297
$97
Opiate(s), drug and metabolites, each procedure
30
$2,024
$26
Injection of trigger points, 1-2 muscles
19
$809
$35
Chemistry procedures
32
$654
$18
Injection, methylprednisolone acetate, 20 mg
18
$42
—None
2013: 2 services
Original Medicare services billed in 2013
Short return visit (20+ min)
58
$2,346
$31
Return visit (30+ min)
22
$1,482
$49
Drugs they prescribed that Part D paid
$3,214
Pharmacies billed $3,214 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 30% of their Part D prescriptions (108 of 355) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
354 generic and fewer than 11 brand-name prescriptions · $3,214 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Gabapentin
38
$615
$16
Celecoxib
29
$498
$17
Tizanidine
78
$364
$5
Hydrocodone-Acetaminophen
46
$310
$7
Cyclobenzaprine
27
$217
$8
See all 8 drugs
Every Part D drug this clinician prescribed
Gabapentin
38
$615
$16
Celecoxib
29
$498
$17
Tizanidine
78
$364
$5
Hydrocodone-Acetaminophen
46
$310
$7
Cyclobenzaprine
27
$217
$8
Oxycodone
17
$197
$12
Methylprednisolone
26
$140
$5
Tramadol
37
$85
$2
Year by year
Part D prescribing by year
2024
355
156
30% (108)
—None
$3,214
2023
768
352
40% (307)
—None
$12,174
2022
752
311
35% (265)
—None
$12,299
2021
902
362
47% (426)
3%
$19,367
2020
891
340
46% (413)
4%
$63,635
2019
802
267
42% (338)
9%
$60,719
2018
870
259
34% (298)
14%
$88,763
2017
1,201
185
37% (439)
20%
$127,757
2016
1,380
228
32% (441)
21%
$140,960
2015
352
108
41% (144)
16%
$29,695
2013
31
16
—None
—None
$761
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
Part D drugs prescribed in 2023
Hydrocodone-Acetaminophen
115
$1,623
$14
Celecoxib
39
$1,520
$39
Gabapentin
65
$1,179
$18
Tizanidine
132
$1,062
$8
Tramadol
115
$709
$6
Methylprednisolone
78
$658
$8
Oxycodone-Acetaminophen
23
$619
$27
Cyclobenzaprine
44
$354
$8
Oxycodone
43
$345
$8
Baclofen
13
$150
$12
Cephalexin
15
$56
$4
Diazepam
21
$23
$1
2022: 12 drugs
Part D drugs prescribed in 2022
Celecoxib
61
$1,970
$32
Tizanidine
136
$1,513
$11
Hydrocodone-Acetaminophen
93
$1,373
$15
Gabapentin
59
$968
$16
Methylprednisolone
67
$516
$8
Oxycodone
45
$512
$11
Tramadol
102
$489
$5
Cyclobenzaprine
38
$400
$11
Oxycodone-Acetaminophen
16
$361
$23
Baclofen
12
$315
$26
Meloxicam
30
$152
$5
Diazepam
14
$9
$1
2021: 13 drugs
Part D drugs prescribed in 2021
Hydrocodone-Acetaminophen
151
$2,170
$14
Tizanidine
134
$2,015
$15
Celecoxib
35
$1,568
$45
Oxycodone
90
$1,287
$14
Pregabalin
17
$909
$53
Tramadol
131
$862
$7
Oxycodone-Acetaminophen
42
$741
$18
Methylprednisolone
79
$712
$9
Gabapentin
52
$622
$12
Baclofen
24
$556
$23
Cyclobenzaprine
28
$308
$11
Meloxicam
22
$100
$5
Diazepam
28
$44
$2
2020: 14 drugs
Part D drugs prescribed in 2020
Oxycontin
18
$11,259
$626
Hydrocodone-Acetaminophen
171
$2,945
$17
Oxycodone-Acetaminophen
44
$2,370
$54
Tizanidine
125
$2,110
$17
Oxycodone
87
$1,451
$17
Gabapentin
78
$1,176
$15
Pregabalin
16
$833
$52
Methylprednisolone
85
$801
$9
Celecoxib
18
$574
$32
Cyclobenzaprine
40
$488
$12
Tramadol
79
$382
$5
Baclofen
25
$361
$14
Meloxicam
17
$116
$7
Diazepam
20
$58
$3
2019: 12 drugs
Part D drugs prescribed in 2019
Lyrica
12
$7,021
$585
Oxycodone-Acetaminophen
54
$3,549
$66
Tizanidine
119
$2,124
$18
Oxycodone
97
$2,114
$22
Hydrocodone-Acetaminophen
76
$1,810
$24
Methylprednisolone
91
$953
$10
Gabapentin
37
$650
$18
Cyclobenzaprine
34
$487
$14
Tramadol
75
$395
$5
Celecoxib
17
$312
$18
Baclofen
23
$311
$14
Diazepam
24
$49
$2
2018: 17 drugs
Part D drugs prescribed in 2018
Lyrica
29
$15,324
$528
Oxycontin
21
$14,232
$678
Hydrocodone-Acetaminophen
65
$2,102
$32
Oxycodone
72
$1,784
$25
Tizanidine
121
$1,730
$14
Gabapentin
77
$1,509
$20
Celecoxib
28
$1,426
$51
Oxycodone-Acetaminophen
29
$1,340
$46
Methylprednisolone
77
$958
$12
Morphine Sulfate Er
16
$946
$59
Duloxetine
15
$735
$49
Baclofen
38
$492
$13
Cyclobenzaprine
34
$347
$10
Tramadol
36
$294
$8
Morphine Sulfate
11
$266
$24
Diazepam
29
$170
$6
Meloxicam
16
$85
$5
2017: 25 drugs
Part D drugs prescribed in 2017
Lyrica
52
$23,635
$455
Butrans
44
$19,058
$433
Nucynta Er
26
$14,931
$574
Movantik
17
$5,983
$352
Belbuca
16
$4,725
$295
Metaxalone
18
$4,133
$230
Tizanidine
164
$3,833
$23
Gabapentin
101
$2,460
$24
Hydrocodone-Acetaminophen
121
$2,209
$18
Duloxetine
41
$1,583
$39
Oxycodone-Acetaminophen
32
$1,406
$44
Morphine Sulfate Er
16
$1,204
$75
Oxycodone
51
$1,127
$22
Celecoxib
23
$1,060
$46
Diclofenac
11
$648
$59
Baclofen
50
$627
$13
Diclofenac
12
$558
$47
Tramadol
58
$541
$9
Methylprednisolone
26
$327
$13
Meloxicam
28
$205
$7
Cyclobenzaprine
24
$174
$7
Morphine Sulfate
12
$167
$14
Diazepam
50
$141
$3
Promethazine
20
$140
$7
Topiramate
16
$56
$3
2016: 26 drugs
Part D drugs prescribed in 2016
Butrans
85
$32,112
$378
Lyrica
50
$18,528
$371
Oxycontin
22
$9,565
$435
Tizanidine
111
$4,040
$36
Metaxalone
21
$3,989
$190
Hydrocodone-Acetaminophen
134
$3,558
$27
Oxycodone
107
$3,282
$31
Nexium
11
$2,818
$256
Duloxetine
59
$2,438
$41
Celecoxib
35
$2,312
$66
Gabapentin
106
$2,044
$19
Diclofenac
19
$1,919
$101
Oxycodone-Acetaminophen
34
$1,645
$48
Voltaren
14
$1,560
$111
Morphine Sulfate Er
23
$1,359
$59
Baclofen
67
$920
$14
Methylprednisolone
38
$565
$15
Tramadol
56
$502
$9
Amitriptyline
25
$494
$20
Nabumetone
14
$261
$19
Diazepam
58
$223
$4
Methocarbamol
18
$181
$10
Clonidine
27
$134
$5
Topiramate
26
$112
$4
Meloxicam
11
$80
$7
Promethazine
14
$46
$3
2015: 13 drugs
Part D drugs prescribed in 2015
Lyrica
15
$5,433
$362
Butrans
15
$5,229
$349
Duloxetine
21
$1,159
$55
Oxycodone
38
$1,013
$27
Hydrocodone-Acetaminophen
36
$910
$25
Oxycodone-Acetaminophen
15
$837
$56
Tizanidine
15
$754
$50
Gabapentin
19
$396
$21
Baclofen
27
$240
$9
Methylprednisolone
11
$192
$17
Diazepam
16
$65
$4
Tramadol
13
$53
$4
Topiramate
12
$47
$4
Money from drug and device companies
$15 in 2024
Industry payments by year
2024
1
1
—None
$15
2023
2
2
—None
$30
2022
3
8
—None
$259
2021
2
8
—None
$161
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.